MIRM

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Mirum Pharmaceuticals Inc

NASDAQ | MIRM

72.88

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$3.65B

Market Cap

-

P/E Ratio

-1.21

EPS

$78.54

52 Week High

$36.88

52 Week Low

HEALTHCARE

Sector

MIRM Chart

Recent Chart
Price Action

MIRM Technicals

Tags:

MIRM Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $255M
Total Revenue $337M
Cost Of Revenue $82M
Costof Goods And Services Sold $82M
Operating Income -$88M
Selling General And Administrative $202M
Research And Development $141M
Operating Expenses $343M
Investment Income Net -
Net Interest Income -$519K
Interest Income $14M
Interest Expense $14M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $24M
Income Before Tax -$87M
Income Tax Expense $1M
Interest And Debt Expense -
Net Income From Continuing Operations -$88M
Comprehensive Income Net Of Tax -
Ebit -$73M
Ebitda -$49M
Net Income -$88M

Revenue & Profitability

Earnings Performance

MIRM Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $671M
Total Current Assets $393M
Cash And Cash Equivalents At Carrying Value $223M
Cash And Short Term Investments $223M
Inventory $22M
Current Net Receivables $78M
Total Non Current Assets $278M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $250M
Intangible Assets Excluding Goodwill $250M
Goodwill -
Investments -
Long Term Investments $13M
Short Term Investments $58M
Other Current Assets $12M
Other Non Current Assets -
Total Liabilities $445M
Total Current Liabilities $127M
Current Accounts Payable $15M
Deferred Revenue -
Current Debt -
Short Term Debt $1.7M
Total Non Current Liabilities $319M
Capital Lease Obligations $9.7M
Long Term Debt $308M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $318M
Other Current Liabilities $112M
Other Non Current Liabilities $2.5M
Total Shareholder Equity $226M
Treasury Stock -
Retained Earnings -$644M
Common Stock $5K
Common Stock Shares Outstanding $48M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $10M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $24M
Capital Expenditures $993K
Change In Receivables -
Change In Inventory -$3.2M
Profit Loss -
Cashflow From Investment -$90M
Cashflow From Financing $18M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$88M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $255M
Total Revenue $337M
Cost Of Revenue $82M
Costof Goods And Services Sold $82M
Operating Income -$88M
Selling General And Administrative $202M
Research And Development $141M
Operating Expenses $343M
Investment Income Net -
Net Interest Income -$519K
Interest Income $14M
Interest Expense $14M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $24M
Income Before Tax -$87M
Income Tax Expense $1M
Interest And Debt Expense -
Net Income From Continuing Operations -$88M
Comprehensive Income Net Of Tax -
Ebit -$73M
Ebitda -$49M
Net Income -$88M

MIRM News

MIRM Profile

Mirum Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Foster City, California, dedicated to developing innovative therapies for debilitating liver diseases. With a strong pipeline of novel treatments, Mirum aims to address significant unmet medical needs in the liver disease space, leveraging cutting-edge science and clinical development expertise. The company's commitment to improving patient outcomes positions it as a key player in the biopharmaceutical market, attractive to institutional investors seeking opportunities in the evolving healthcare landscape.

VHAI
-25.00%
$0.00
YYAI
-12.21%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
ELBM
+334.95%
$7.17
PLUG
+13.44%
$3.87
GWH
+149.66%
$10.38
RGTI
+20.26%
$52.82
ASST
-35.33%
$1.00
BITF
+25.47%
$5.26
IONZ
-35.04%
$2.21
BYND
-47.01%
$1.06
NVDA
+2.25%
$187.29
NVTS
+23.51%
$10.16
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
JOBY
+2.61%
$16.70
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
TSLA
+5.01%
$434.23
CLF
+5.50%
$13.90
F
+0.96%
$11.52
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
ETHD
-11.62%
$3.37
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
RXRX
+4.41%
$5.55
CIFR
+19.77%
$20.32
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
TLRY
+0.58%
$1.73
DFLI
+41.35%
$1.54
ONDS
+18.43%
$10.92
RR
+7.85%
$6.38
ACHR
+6.64%
$12.76
SOUN
+10.77%
$19.23
WBD
-3.22%
$17.10
MP
+23.30%
$96.60
NAK
+26.47%
$2.56
USAR
+22.60%
$39.97
RMBL
+60.50%
$3.21
IREN
+8.04%
$64.58
ABAT
+34.34%
$9.06
ADD
-25.47%
$0.05
CORZ
+2.66%
$18.52
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
EPWK
-11.00%
$0.08
NAKA
-4.05%
$0.83
UAMY
+37.67%
$16.80
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
PFE
+0.10%
$24.80
ADAP
-0.70%
$0.18
BMNR
+7.40%
$56.35
QUBT
+10.49%
$21.01
GDXD
-12.99%
$0.74
SNAP
+3.14%
$8.02
XCH
+119.76%
$1.81
CJET
-14.93%
$0.12
MRVL
-5.52%
$85.61
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
RF
+1.84%
$24.60
QSI
+23.35%
$2.06
HPE
+2.76%
$25.07
PMAX
+75.28%
$4.54
TMC
+18.40%
$10.52
ABEV
+1.42%
$2.14
KDP
+3.02%
$26.60
RGTZ
-42.68%
$10.66
T
-1.10%
$25.58
SMR
+15.95%
$45.50
VHAI
-25.00%
$0.00
YYAI
-12.21%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
ELBM
+334.95%
$7.17
PLUG
+13.44%
$3.87
GWH
+149.66%
$10.38
RGTI
+20.26%
$52.82
ASST
-35.33%
$1.00
BITF
+25.47%
$5.26
IONZ
-35.04%
$2.21
BYND
-47.01%
$1.06
NVDA
+2.25%
$187.29
NVTS
+23.51%
$10.16
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
JOBY
+2.61%
$16.70
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
TSLA
+5.01%
$434.23
CLF
+5.50%
$13.90
F
+0.96%
$11.52
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
ETHD
-11.62%
$3.37
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
RXRX
+4.41%
$5.55
CIFR
+19.77%
$20.32
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
TLRY
+0.58%
$1.73
DFLI
+41.35%
$1.54
ONDS
+18.43%
$10.92
RR
+7.85%
$6.38
ACHR
+6.64%
$12.76
SOUN
+10.77%
$19.23
WBD
-3.22%
$17.10
MP
+23.30%
$96.60
NAK
+26.47%
$2.56
USAR
+22.60%
$39.97
RMBL
+60.50%
$3.21
IREN
+8.04%
$64.58
ABAT
+34.34%
$9.06
ADD
-25.47%
$0.05
CORZ
+2.66%
$18.52
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
EPWK
-11.00%
$0.08
NAKA
-4.05%
$0.83
UAMY
+37.67%
$16.80
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
PFE
+0.10%
$24.80
ADAP
-0.70%
$0.18
BMNR
+7.40%
$56.35
QUBT
+10.49%
$21.01
GDXD
-12.99%
$0.74
SNAP
+3.14%
$8.02
XCH
+119.76%
$1.81
CJET
-14.93%
$0.12
MRVL
-5.52%
$85.61
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
RF
+1.84%
$24.60
QSI
+23.35%
$2.06
HPE
+2.76%
$25.07
PMAX
+75.28%
$4.54
TMC
+18.40%
$10.52
ABEV
+1.42%
$2.14
KDP
+3.02%
$26.60
RGTZ
-42.68%
$10.66
T
-1.10%
$25.58
SMR
+15.95%
$45.50
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.